Nan Shan Life Insurance Co. Ltd. Decreases Stock Holdings in CVS Health Corporation $CVS

Nan Shan Life Insurance Co. Ltd. cut its holdings in CVS Health Corporation (NYSE:CVS) by 45.6% in the second quarter, HoldingsChannel reports. The firm owned 223,565 shares of the pharmacy operator’s stock after selling 187,485 shares during the quarter. Nan Shan Life Insurance Co. Ltd.’s holdings in CVS Health were worth $23,128,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of CVS. BlackRock Inc. purchased a new position in shares of CVS Health in the 2nd quarter worth $12,747,462,000. State Street Corp raised its position in shares of CVS Health by 2.1% during the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after buying an additional 1,245,457 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of CVS Health by 49.8% in the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after acquiring an additional 11,233,381 shares during the last quarter. Capital International Investors lifted its holdings in shares of CVS Health by 3.4% in the 4th quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock valued at $2,189,793,000 after acquiring an additional 900,153 shares during the last quarter. Finally, Bank of America Corp DE increased its stake in CVS Health by 148.0% during the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after acquiring an additional 13,836,701 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the subject of several analyst reports. Royal Bank Of Canada raised their price objective on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. UBS Group increased their price target on CVS Health from $122.00 to $126.00 and gave the company a “buy” rating in a report on Thursday, August 6th. DA Davidson lifted their price objective on shares of CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. HSBC reiterated a “hold” rating and set a $103.00 price objective on shares of CVS Health in a research report on Monday, July 6th. Finally, Sanford C. Bernstein raised their target price on shares of CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a report on Tuesday, May 12th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Stock Performance

CVS stock opened at $97.36 on Wednesday. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The firm has a market cap of $124.52 billion, a price-to-earnings ratio of 25.76, a PEG ratio of 0.92 and a beta of 0.59. The business’s fifty day simple moving average is $101.18 and its two-hundred day simple moving average is $89.82. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business’s revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.7%. CVS Health’s dividend payout ratio (DPR) is 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.